haloperidol has been researched along with Disruptive, Impulse Control, and Conduct Disorders in 5 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
Disruptive, Impulse Control, and Conduct Disorders: Disorders whose essential features are the failure to resist an impulse, drive, or temptation to perform an act that is harmful to the individual or to others. Individuals experience an increased sense of tension prior to the act and pleasure, gratification or release of tension at the time of committing the act.
| Excerpt | Relevance | Reference |
|---|---|---|
| "44 patients with chronic DSM-IV schizophrenia were treated with clozapine or haloperidol decanoate in an open prospective 6-month trial." | 9.10 | The effects of clozapine versus haloperidol on measures of impulsive aggression and suicidality in chronic schizophrenia patients: an open, nonrandomized, 6-month study. ( Mester, R; Shabash, E; Sheitman, B; Spivak, B; Weizman, A, 2003) |
| "44 patients with chronic DSM-IV schizophrenia were treated with clozapine or haloperidol decanoate in an open prospective 6-month trial." | 5.10 | The effects of clozapine versus haloperidol on measures of impulsive aggression and suicidality in chronic schizophrenia patients: an open, nonrandomized, 6-month study. ( Mester, R; Shabash, E; Sheitman, B; Spivak, B; Weizman, A, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ozcan, O | 1 |
| Selimoğlu, MA | 1 |
| Nakamae, T | 1 |
| Spivak, B | 1 |
| Shabash, E | 1 |
| Sheitman, B | 1 |
| Weizman, A | 1 |
| Mester, R | 1 |
| Strawn, JR | 1 |
| Keck, PE | 1 |
| O'Brien, CP | 1 |
| DiGiacomo, JN | 1 |
| Webb, W | 1 |
1 review available for haloperidol and Disruptive, Impulse Control, and Conduct Disorders
| Article | Year |
|---|---|
[Diversity of obsessive-compulsive disorder and pharmacotherapy associated with obsessive-compulsive spectrum disorders].
Topics: Antipsychotic Agents; Autistic Disorder; Body Dysmorphic Disorders; Clomipramine; Comorbidity; Disru | 2011 |
2 trials available for haloperidol and Disruptive, Impulse Control, and Conduct Disorders
| Article | Year |
|---|---|
The effects of clozapine versus haloperidol on measures of impulsive aggression and suicidality in chronic schizophrenia patients: an open, nonrandomized, 6-month study.
Topics: Adolescent; Adult; Aggression; Antipsychotic Agents; Chronic Disease; Clozapine; Diagnostic and Stat | 2003 |
Management of hostile, suspicious patients. Trifluoperazine versus haloperidol.
Topics: Adult; Antipsychotic Agents; Disruptive, Impulse Control, and Conduct Disorders; Double-Blind Method | 1974 |
2 other studies available for haloperidol and Disruptive, Impulse Control, and Conduct Disorders
| Article | Year |
|---|---|
Self-injury behavior in an adolescent with Wilson's disease.
Topics: Adolescent; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Brain; Citalopram; Diagn | 2009 |
Early bicarbonate loading and dantroline for ziprasidone/haloperidol-induced neuroleptic malignant syndrome.
Topics: Adolescent; Antipsychotic Agents; Autistic Disorder; Combined Modality Therapy; Dantrolene; Disrupti | 2006 |